Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imipenem Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101973915A details a cost-effective synthesis of carbapenem intermediate 4-BMA using a recoverable chiral sulfonamide auxiliary for improved stereoselectivity.